MedPath

Duration of Prophylaxis against Venous Thromboembolism with Low Molecular Weight heparin (Enoxaparin Sodium) after Major Abdominal Surgery.

Not Applicable
Completed
Conditions
VTE(venous thromboembolism)
Registration Number
JPRN-UMIN000007262
Lead Sponsor
Yamaguchi University Graduate School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

severe renal insufficiency known hypersensitivity to Enoxaparin Sodium treatment with anticoagulant therapy before surgery generalized bleeding disorder

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Patients were randomly assigned to receive Low Molecular Weight heparin (Enoxaparin Sodium) for 3days or 10days. Venous ultrasonography was performed after 11days. The end point to with respect to efficacy was the incidence of venous thromboembolism.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath